Centenary Institute scientists have conducted a study which could change how researchers discover the causes of genetic heart disease. At the moment, the bulk of genetic testing focuses on the protein-coding sections of DNA to look for disease-causing variants. However, these protein-coding regions only make up about two-per-cent of our
The Centenary Institute has collaborated with fellow medical research institute, the Hudson Institute in Victoria, to develop a novel model system for accurately monitoring tumour stage and immune cells involvement. Head of Centenary’s Liver Enzymes in Metabolism and Inflammation Program, Professor Mark Gorrell, was involved in the research project. Ovarian
Dr Ka Ka Ting, a researcher within Centenary’s Vascular Biology Program, has had one of her images featured on the front cover of scientific journal Diabetologia. Recently, Dr Ting led a study which found a novel drug (developed by Centenary scientists) could be used to effectively treat diabetic retinopathy; the main
Congratulations Dr Ulf Schmitz who has been awarded a 2019 Australia-India Strategic Research Fund (AISRF) Early-and-Mid-Career Researcher (EMCR) Fellowship. Dr Schmitz is Head of the Computational BioMedicine Laboratory within Centenary’s Gene and Stem Cell Program. The AISRF EMCR Fellowship scheme offers successful applicants financial support worth up to $16,500 to
We would like to wish our generous supporters a safe and happy Christmas and New Year! This year, your belief in our life-saving researcher has helped us: Improve the diagnosis rate of a potentially deadly heart condition by up to 20 per cent. Discover a potential new pathway for cancer
Researchers at the Centenary Institute in Sydney have led a study which has uncovered a brand-new target for melanoma metastasis; providing an improved understanding of how the cancer spreads and opening the door for more effective treatments. Australia and New Zealand have the highest rates of melanoma in the world.